T
Gd-based nanoparticle
MPRAGE
T1 map
theranostic agent
tumor
Journal
Journal of magnetic resonance imaging : JMRI
ISSN: 1522-2586
Titre abrégé: J Magn Reson Imaging
Pays: United States
ID NLM: 9105850
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
revised:
17
10
2022
received:
08
07
2022
accepted:
18
10
2022
medline:
12
6
2023
pubmed:
1
11
2022
entrez:
31
10
2022
Statut:
ppublish
Résumé
The measurement of the concentration of theranostic agents in vivo is essential for the assessment of their therapeutic efficacy and their safety regarding healthy tissue. To this end, there is a need for quantitative T To generate T Pilot. Solutions containing contrast agents (chelated Gd A 3-T and 7-T, saturation recovery (SR), and MPRAGE sequences. The MPRAGE T A linear model was used to characterize the relation between T The slope of the linear model was 0.966 (R The T 2. Stage 1.
Sections du résumé
BACKGROUND
BACKGROUND
The measurement of the concentration of theranostic agents in vivo is essential for the assessment of their therapeutic efficacy and their safety regarding healthy tissue. To this end, there is a need for quantitative T
PURPOSE
OBJECTIVE
To generate T
STUDY TYPE
METHODS
Pilot.
PHANTOM/ANIMAL MODEL/POPULATION
UNASSIGNED
Solutions containing contrast agents (chelated Gd
FIELD STRENGTH/SEQUENCE
UNASSIGNED
A 3-T and 7-T, saturation recovery (SR), and MPRAGE sequences.
ASSESSMENT
RESULTS
The MPRAGE T
STATISTICAL TESTS
METHODS
A linear model was used to characterize the relation between T
RESULTS
RESULTS
The slope of the linear model was 0.966 (R
DATA CONCLUSION
CONCLUSIONS
The T
EVIDENCE LEVEL
METHODS
2.
TECHNICAL EFFICACY
UNASSIGNED
Stage 1.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
313-323Subventions
Organisme : IdEx Bordeaux (10-IDEX-0003)
Organisme : Laboratory of Excellence TRAIL ANR-10-LABX-57
Informations de copyright
© 2022 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.
Références
Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010;62:1064-1079.
Mura S, Couvreur P. Nanotheranostics for personalized medicine. Adv Drug Deliv Rev 2012;64:1394-1416.
Bonvalot S, Le Pechoux C, De Baere T, et al. First-in-human study testing a new radioenhancer using nanoparticles (NBTXR3) activated by radiation therapy in patients with locally advanced soft tissue sarcomas. Clin Cancer Res off J Am Assoc Cancer Res 2017;23:908-917.
Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine 2013;8:2521-2532.
Yan Z, Zhang X, Liu Y, et al. HSA-MnO2-131I combined imaging and treatment of anaplastic thyroid carcinoma. Technol Cancer Res Treat 2022;21:15330338221106556.
Verry C, Dufort S, Villa J, et al. Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial). Radiother Oncol 2021;160:159-165.
Kadria-Vili Y, Neumann O, Zhao Y, et al. Gd2O3-mesoporous silica/gold nanoshells: A potential dual T1/T2 contrast agent for MRI-guided localized near-IR photothermal therapy. Proc Natl Acad Sci U S A 2022;119:2123527119.
Muir BW, Acharya DP, Kennedy DF, et al. Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticles. Biomaterials 2012;33:2723-2733.
Liu Y, Chen Z, Liu C, Yu D, Lu Z, Zhang N. Gadolinium-loaded polymeric nanoparticles modified with anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials 2011;32:5167-5176.
Wang L, Xing H, Zhang S, et al. A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery. Biomaterials 2013;34:3390-3401.
Lux F, Sancey L, Bianchi A, Crémillieux Y, Roux S, Tillement O. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization. Nanomedicine 2015;10:1801-1815.
Verry C, Dufort S, Lemasson B, et al. Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective. Sci Adv 2020;6:eaay5279.
Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev 2019;138:302-325.
Wang L, Lai S-M, Li C-Z, Yu H-P, Venkatesan P, Lai P-S. D-alpha-tocopheryl poly(ethylene glycol 1000) succinate-coated manganese-zinc ferrite nanomaterials for a dual-mode magnetic resonance imaging contrast agent and hyperthermia treatments. Pharmaceutics 2022;14:1000-1019.
Haar PJ, Broaddus WC, Chen Z, Fatouros PP, Gillies GT, Corwin FD. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy. Phys Med Biol 2010;55:3451-3465.
Coolen BF, Geelen T, Paulis LEM, Nicolay K, Strijkers GJ. Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping. J Cardiovasc Magn Reson off J Soc Cardiovasc Magn Reson 2011;13:56-65.
Crawley AP, Henkelman RM. A comparison of one-shot and recovery methods in T1 imaging. Magn Reson Med 1988;7:23-34.
Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41:250-251.
Stikov N, Boudreau M, Levesque IR, Tardif CL, Barral JK, Pike GB. On the accuracy of T1 mapping: Searching for common ground. Magn Reson Med 2015;73:514-522.
Subashi E, Choudhury KR, Johnson GA. An analysis of the uncertainty and bias in DCE-MRI measurements using the spoiled gradient-recalled echo pulse sequence. Med Phys 2014;41:032301.
Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele P-F, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage 2010;49:1271-1281.
Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
Gowland PA, Leach MO. Fast and accurate measurements of T1 using a multi-readout single inversion-recovery sequence. Magn Reson Med 1992;26:79-88.
Wang J, He L, Zheng H, Lu Z-L. Optimizing the magnetization-prepared rapid gradient-Echo (MP-RAGE) sequence. PLoS One 2014;9:e96899.
Ting Y-L, Bendel P. Thin-section MR imaging of rat brain at 4.7 T. J Magn Reson Imaging 1992;2:393-399.
Hagiwara A, Fujimoto K, Kamagata K, et al. Age-related changes in relaxation times, proton density, myelin, and tissue volumes in adult brain analyzed by 2-dimensional quantitative synthetic magnetic resonance imaging. Invest Radiol 2021;56:163-172.
Cohen-Adad J. What can we learn from T2* maps of the cortex? Neuroimage 2014;93:189-200.
Péran P, Hagberg G, Luccichenti G, et al. Voxel-based analysis of R2* maps in the healthy human brain. J Magn Reson Imaging 2007;26:1413-1420.
Vayssières L, Chanéac C, Tronc E, Jolivet JP. Size tailoring of magnetite particles formed by aqueous precipitation: An example of thermodynamic stability of nanometric oxide particles. J Colloid Interface Sci 1998;205:205-212.
Adumeau L, Genevois C, Roudier L, Schatz C, Couillaud F, Mornet S. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors. Biochim Biophys Acta Gen Subj 2017;1861:1587-1596.
Lux F, Mignot A, Mowat P, et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl 2011;50:12299-12303.
Deruelle T, Kober F, Perles-Barbacaru A, et al. A multicenter preclinical MRI study: Definition of rat brain relaxometry reference maps. Front Neuroinform 2020;14:22.
Shin W, Gu H, Yang Y. Fast high-resolution T1 mapping using inversion-recovery Look-Locker echo-planar imaging at steady state: Optimization for accuracy and reliability. Magn Reson Med 2009;61:899-906.
Bojorquez JZ, Bricq S, Acquitter C, Brunotte F, Walker PM, Lalande A. What are normal relaxation times of tissues at 3 T? Magn Reson Imaging 2017;35:69-80.
Patil V, Johnson G. ΔR2 (*) gadolinium-diethylenetriaminepentacetic acid relaxivity in venous blood. Magn Reson Med 2013;69:1104-1108.
Randall JW, Rammohan N, Das IJ, Yadav P. Towards accurate and precise image-guided radiotherapy: Clinical applications of the MR-Linac. J Clin Med 2022;11:4044-4061.
Werensteijn-Honingh AM, Kroon PS, Winkel D, et al. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases. Phys Imaging Radiat Oncol 2022;23:66-73.